Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Books
  • Manufacturing
  • Real Estate
  • Technology
  • Entertainment
  • Health
ncarol.com

Elixia Announces New Hire Sam Searcy as Chief Commercial Officer
ncarol.com/10213312

Trending...
  • Virtually Tour Heritage at South Brunswick's Resort-Style Living - Experience Indoor and Outdoor Amenities at Your Fingertips
  • Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
Elixia
Sam Searcy joins Elixia, a site management organization, to oversee and increase business growth.

RESEARCH TRIANGLE PARK, N.C. - ncarol.com -- Elixia proudly welcomes Sam Searcy as the company's Chief Commercial Officer. Searcy will oversee activities related to marketing, enhance service offerings, expand Elixia's national site network, maintain client customer service, strategize Elixia's business growth, and increase Elixia's overall market share. Searcy will also manage Elixia's RTP office and the N.C.-based operations team.

"I am thrilled to have the opportunity to work with such a talented team. Elixia is truly implementing a breakthrough approach to clinical trials" Sam Searcy, CCO Searcy joins Elixia as an influential business and community leader with over 10 years of executive leadership roles in small and medium-sized companies in the life science sector. Searcy has a proven track record of building strong, efficient, and productive executive teams, and launching industry-disrupting products and services. Searcy also focuses on community as he serves on a number of corporate and volunteer Boards, including the N.C. Community College System, Appalachian State University Board of Visitors and ICE Global Consulting. He also serves as a Senior Advisor to NeuroVice, a Triangle-based medical device company focused on the medical needs of patients with various seizure disorders.

More on ncarol.com
  • Men Moving Mountains Expands Full-Service Moving Options in Boone, NC and the High Country
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
  • OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
  • Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach

"We are excited to have Sam join the Elixia team. Sam's years of experience in life sciences will help Elixia navigate our current period of rapid growth." Neal Patel, CEO. The addition of Searcy will add value to the Elixia team, accelerate the company's goals, and support Elixia's overall mission.

About Elixia

Elixia is a tech-enabled clinical site organization specializing in Cardiology, Nephrology, Behavioral Health, and Infectious disease trials. Elixia's mission: To provide pharmaceutical companies with a breakthrough approach to clinical trials while empowering physician research, reinventing access to diverse populations, and accelerating the collection of data vital to high-quality clinical research outcomes while comprehensively supporting the drug development process. Elixia maintains corporate headquarters in Palm Beach FL, and the Research Triangle Park.

Contact
Melinda Jackson Public Relations
***@melindajacksonpr.com


Source: Elixia
Filed Under: Technology

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Advantage Newspaper Consultants Celebrates 30 Years of Serving the Newspaper Industry
  • Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
  • [New Book] "Historic Maps of Charlotte" Available Now!
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • 2026 Triangle Parade of Homes Features Over 300 Homes
  • "Next Friday" Star Mike Epps Hits Cherokee as KayeDinero Drops "Cherokee"
  • P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January
  • Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
  • Travel Season Turns to the Smokies as KayeDinero Turns Cherokee Into a Song
  • DBF Viewer 2000 v9.32 Adds New Control for Data Export
  • Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
  • Cabinet Revolution Expands Affordable Cabinet Options for High Country Homes
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
  • Shuttle Buddy Announces Amazon Partnership to Launch Workforce Express in North Carolina
  • Inlow Upholstery Helps Cleveland County Homeowners Refresh Furniture with Custom Upholstery
  • Birthstones Are Having a 2026 Moment. KayeDinero's "Aquamarine" Began With Her Grandmother
_catLbl0 _catLbl1

Popular on ncarol.com

  • Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing - 178
  • Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 160
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 152
  • Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million - 133
  • Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB) - 111
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center - 111
  • ChargeOn Announces Conversational Payment Management Solution - 103
  • Paul Ohana - From Beverly Hills Salon Chair To Beauty Founder Celebrity Hair Expert - 101
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP) - 101
  • Santa Your Way Announces Official 2026 Q4 Holiday Tour: Booking Open For Santa, The 5-star Grinch, And Dual Character Experiences Nationwide

Similar on ncarol.com

  • NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
  • 3ptechies Makes Its Articles Audio-Ready With Instaread Voice Technology
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute